. | Norwood (n = 678) . | Hybrid (n = 82) . | . | ||
---|---|---|---|---|---|
Variable . | Mean (SD) . | Median (IQR) . | Mean (SD) . | Median (IQR) . | P-value . |
Continuous factors | |||||
Ascending aorta (mm) | 3.6 (1.9) | 3.2 (2.0–5.0) | 4.4 (1.9) | 4.0 (3.0–5.8) | <0.001 |
Age at Norwood (days) | 5.5 (9.0) | 4.0 (2.5–6.0) | 9.7 (16.2) | 5.2 (3.4–9.6) | 0.036 |
Birth weight (kg) | 3.1 (0.6) | 3.2 (2.8–3.5) | 2.7 (0.7) | 2.9 (2.1–3.2) | <0.001 |
Gestational age (weeks) | 38.1 (1.7) | 38.0 (37.0–39.0) | 36.2 (2.8) | 37.0 (34.0–38.0) | <0.001 |
Year of Norwood | 2011 (2006–2016) | 2019 (2013–2020) | <0.001 | ||
Categorical factors | |||||
n (%) | n (%) | ||||
APVR | 0.007 | ||||
None | 653 (96.3) | 73 (89.0) | |||
Present | 25 (3.7) | 9 (11.0) | |||
AVVR | <0.001 | ||||
No/trace/mild | 609 (89.8) | 62 (75.6) | |||
Moderate/severe | 69 (10.2) | 20 (24.4) | |||
Era | <0.001 | ||||
2004–2008 | 268 (39.5) | 7 (8.5) | |||
2009–2014 | 186 (27.4) | 16 (19.5) | |||
2015–2018 | 120 (17.7) | 15 (18.3) | |||
2019–2022 | 104 (15.3) | 44 (53.7) | |||
Sex | 0.292 | ||||
Male | 421 (62.1) | 46 (56.1) | |||
Female | 257 (37.9) | 36 (43.9) | |||
Genetic anomaly | <0.001 | ||||
Normal | 531 (78.3) | 44 (53.7) | |||
Confirmed/suspect | 147 (21.7) | 38 (46.3) | |||
HLHS subtype | 0.001 | ||||
AA/MA | 227 (33.5) | 13 (15.8) | |||
AA/MS | 121 (17.8) | 12 (14.6) | |||
AS/MA; AS/MS | 127 (18.7) | 18 (22.0) | |||
HLHS variant | 203 (29.9) | 39 (47.6) | |||
Atrial septal restriction | 0.042 | ||||
None | 599 (88.4) | 66 (80.5) | |||
Yes | 79 (11.6) | 16 (19.5) | |||
Preterm birth | <0.001 | ||||
Term (37+ weeks) | 596 (87.9) | 47 (57.3) | |||
Preterm (<37 weeks) | 82 (12.1) | 35 (42.7) | |||
Race | 0.266 | ||||
Caucasian | 406 (60.1) | 46 (57.5) | |||
African American | 108 (16.0) | 9 (11.2) | |||
Other | 162 (24.0) | 25 (31.2) | |||
Weight at surgery | <0.001 | ||||
≤2.5 kg | 90 (13.3) | 28 (34.2) | |||
2.5 kg + | 588 (86.7) | 54 (65.8) |
. | Norwood (n = 678) . | Hybrid (n = 82) . | . | ||
---|---|---|---|---|---|
Variable . | Mean (SD) . | Median (IQR) . | Mean (SD) . | Median (IQR) . | P-value . |
Continuous factors | |||||
Ascending aorta (mm) | 3.6 (1.9) | 3.2 (2.0–5.0) | 4.4 (1.9) | 4.0 (3.0–5.8) | <0.001 |
Age at Norwood (days) | 5.5 (9.0) | 4.0 (2.5–6.0) | 9.7 (16.2) | 5.2 (3.4–9.6) | 0.036 |
Birth weight (kg) | 3.1 (0.6) | 3.2 (2.8–3.5) | 2.7 (0.7) | 2.9 (2.1–3.2) | <0.001 |
Gestational age (weeks) | 38.1 (1.7) | 38.0 (37.0–39.0) | 36.2 (2.8) | 37.0 (34.0–38.0) | <0.001 |
Year of Norwood | 2011 (2006–2016) | 2019 (2013–2020) | <0.001 | ||
Categorical factors | |||||
n (%) | n (%) | ||||
APVR | 0.007 | ||||
None | 653 (96.3) | 73 (89.0) | |||
Present | 25 (3.7) | 9 (11.0) | |||
AVVR | <0.001 | ||||
No/trace/mild | 609 (89.8) | 62 (75.6) | |||
Moderate/severe | 69 (10.2) | 20 (24.4) | |||
Era | <0.001 | ||||
2004–2008 | 268 (39.5) | 7 (8.5) | |||
2009–2014 | 186 (27.4) | 16 (19.5) | |||
2015–2018 | 120 (17.7) | 15 (18.3) | |||
2019–2022 | 104 (15.3) | 44 (53.7) | |||
Sex | 0.292 | ||||
Male | 421 (62.1) | 46 (56.1) | |||
Female | 257 (37.9) | 36 (43.9) | |||
Genetic anomaly | <0.001 | ||||
Normal | 531 (78.3) | 44 (53.7) | |||
Confirmed/suspect | 147 (21.7) | 38 (46.3) | |||
HLHS subtype | 0.001 | ||||
AA/MA | 227 (33.5) | 13 (15.8) | |||
AA/MS | 121 (17.8) | 12 (14.6) | |||
AS/MA; AS/MS | 127 (18.7) | 18 (22.0) | |||
HLHS variant | 203 (29.9) | 39 (47.6) | |||
Atrial septal restriction | 0.042 | ||||
None | 599 (88.4) | 66 (80.5) | |||
Yes | 79 (11.6) | 16 (19.5) | |||
Preterm birth | <0.001 | ||||
Term (37+ weeks) | 596 (87.9) | 47 (57.3) | |||
Preterm (<37 weeks) | 82 (12.1) | 35 (42.7) | |||
Race | 0.266 | ||||
Caucasian | 406 (60.1) | 46 (57.5) | |||
African American | 108 (16.0) | 9 (11.2) | |||
Other | 162 (24.0) | 25 (31.2) | |||
Weight at surgery | <0.001 | ||||
≤2.5 kg | 90 (13.3) | 28 (34.2) | |||
2.5 kg + | 588 (86.7) | 54 (65.8) |
HLHS subtypes: AA/MA: aortic atresia/mitral atresia; AA/MS: aortic atresia/mitral stenosis; AS/MA: AS/MS: aortic stenosis/mitral atresia and aortic stenosis/mitral stenosis (combined for modelling due to small sample sizes); variant: HLHS variant.
APVR: anomalous pulmonary venous return; AVVR: atrioventricular valve regurgitation; IQR: interquartile range; HLHS: hypoplastic left heart syndrome; SD: standard deviation.
. | Norwood (n = 678) . | Hybrid (n = 82) . | . | ||
---|---|---|---|---|---|
Variable . | Mean (SD) . | Median (IQR) . | Mean (SD) . | Median (IQR) . | P-value . |
Continuous factors | |||||
Ascending aorta (mm) | 3.6 (1.9) | 3.2 (2.0–5.0) | 4.4 (1.9) | 4.0 (3.0–5.8) | <0.001 |
Age at Norwood (days) | 5.5 (9.0) | 4.0 (2.5–6.0) | 9.7 (16.2) | 5.2 (3.4–9.6) | 0.036 |
Birth weight (kg) | 3.1 (0.6) | 3.2 (2.8–3.5) | 2.7 (0.7) | 2.9 (2.1–3.2) | <0.001 |
Gestational age (weeks) | 38.1 (1.7) | 38.0 (37.0–39.0) | 36.2 (2.8) | 37.0 (34.0–38.0) | <0.001 |
Year of Norwood | 2011 (2006–2016) | 2019 (2013–2020) | <0.001 | ||
Categorical factors | |||||
n (%) | n (%) | ||||
APVR | 0.007 | ||||
None | 653 (96.3) | 73 (89.0) | |||
Present | 25 (3.7) | 9 (11.0) | |||
AVVR | <0.001 | ||||
No/trace/mild | 609 (89.8) | 62 (75.6) | |||
Moderate/severe | 69 (10.2) | 20 (24.4) | |||
Era | <0.001 | ||||
2004–2008 | 268 (39.5) | 7 (8.5) | |||
2009–2014 | 186 (27.4) | 16 (19.5) | |||
2015–2018 | 120 (17.7) | 15 (18.3) | |||
2019–2022 | 104 (15.3) | 44 (53.7) | |||
Sex | 0.292 | ||||
Male | 421 (62.1) | 46 (56.1) | |||
Female | 257 (37.9) | 36 (43.9) | |||
Genetic anomaly | <0.001 | ||||
Normal | 531 (78.3) | 44 (53.7) | |||
Confirmed/suspect | 147 (21.7) | 38 (46.3) | |||
HLHS subtype | 0.001 | ||||
AA/MA | 227 (33.5) | 13 (15.8) | |||
AA/MS | 121 (17.8) | 12 (14.6) | |||
AS/MA; AS/MS | 127 (18.7) | 18 (22.0) | |||
HLHS variant | 203 (29.9) | 39 (47.6) | |||
Atrial septal restriction | 0.042 | ||||
None | 599 (88.4) | 66 (80.5) | |||
Yes | 79 (11.6) | 16 (19.5) | |||
Preterm birth | <0.001 | ||||
Term (37+ weeks) | 596 (87.9) | 47 (57.3) | |||
Preterm (<37 weeks) | 82 (12.1) | 35 (42.7) | |||
Race | 0.266 | ||||
Caucasian | 406 (60.1) | 46 (57.5) | |||
African American | 108 (16.0) | 9 (11.2) | |||
Other | 162 (24.0) | 25 (31.2) | |||
Weight at surgery | <0.001 | ||||
≤2.5 kg | 90 (13.3) | 28 (34.2) | |||
2.5 kg + | 588 (86.7) | 54 (65.8) |
. | Norwood (n = 678) . | Hybrid (n = 82) . | . | ||
---|---|---|---|---|---|
Variable . | Mean (SD) . | Median (IQR) . | Mean (SD) . | Median (IQR) . | P-value . |
Continuous factors | |||||
Ascending aorta (mm) | 3.6 (1.9) | 3.2 (2.0–5.0) | 4.4 (1.9) | 4.0 (3.0–5.8) | <0.001 |
Age at Norwood (days) | 5.5 (9.0) | 4.0 (2.5–6.0) | 9.7 (16.2) | 5.2 (3.4–9.6) | 0.036 |
Birth weight (kg) | 3.1 (0.6) | 3.2 (2.8–3.5) | 2.7 (0.7) | 2.9 (2.1–3.2) | <0.001 |
Gestational age (weeks) | 38.1 (1.7) | 38.0 (37.0–39.0) | 36.2 (2.8) | 37.0 (34.0–38.0) | <0.001 |
Year of Norwood | 2011 (2006–2016) | 2019 (2013–2020) | <0.001 | ||
Categorical factors | |||||
n (%) | n (%) | ||||
APVR | 0.007 | ||||
None | 653 (96.3) | 73 (89.0) | |||
Present | 25 (3.7) | 9 (11.0) | |||
AVVR | <0.001 | ||||
No/trace/mild | 609 (89.8) | 62 (75.6) | |||
Moderate/severe | 69 (10.2) | 20 (24.4) | |||
Era | <0.001 | ||||
2004–2008 | 268 (39.5) | 7 (8.5) | |||
2009–2014 | 186 (27.4) | 16 (19.5) | |||
2015–2018 | 120 (17.7) | 15 (18.3) | |||
2019–2022 | 104 (15.3) | 44 (53.7) | |||
Sex | 0.292 | ||||
Male | 421 (62.1) | 46 (56.1) | |||
Female | 257 (37.9) | 36 (43.9) | |||
Genetic anomaly | <0.001 | ||||
Normal | 531 (78.3) | 44 (53.7) | |||
Confirmed/suspect | 147 (21.7) | 38 (46.3) | |||
HLHS subtype | 0.001 | ||||
AA/MA | 227 (33.5) | 13 (15.8) | |||
AA/MS | 121 (17.8) | 12 (14.6) | |||
AS/MA; AS/MS | 127 (18.7) | 18 (22.0) | |||
HLHS variant | 203 (29.9) | 39 (47.6) | |||
Atrial septal restriction | 0.042 | ||||
None | 599 (88.4) | 66 (80.5) | |||
Yes | 79 (11.6) | 16 (19.5) | |||
Preterm birth | <0.001 | ||||
Term (37+ weeks) | 596 (87.9) | 47 (57.3) | |||
Preterm (<37 weeks) | 82 (12.1) | 35 (42.7) | |||
Race | 0.266 | ||||
Caucasian | 406 (60.1) | 46 (57.5) | |||
African American | 108 (16.0) | 9 (11.2) | |||
Other | 162 (24.0) | 25 (31.2) | |||
Weight at surgery | <0.001 | ||||
≤2.5 kg | 90 (13.3) | 28 (34.2) | |||
2.5 kg + | 588 (86.7) | 54 (65.8) |
HLHS subtypes: AA/MA: aortic atresia/mitral atresia; AA/MS: aortic atresia/mitral stenosis; AS/MA: AS/MS: aortic stenosis/mitral atresia and aortic stenosis/mitral stenosis (combined for modelling due to small sample sizes); variant: HLHS variant.
APVR: anomalous pulmonary venous return; AVVR: atrioventricular valve regurgitation; IQR: interquartile range; HLHS: hypoplastic left heart syndrome; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.